{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_004494.4:c.5095T>C",
          "cDNA Change": {
            "transcript": "NM_004494.4",
            "ref": "T",
            "alt": "C",
            "position": "5095"
          },
          "Protein Change": {
            "ref": "Y",
            "alt": "C",
            "position": "1699"
          },
          "Description in input context": "Y1699C"
        },
        {
          "HGVS": "NM_004494.4:c.6055G>A",
          "cDNA Change": {
            "transcript": "NM_004494.4",
            "ref": "G",
            "alt": "A",
            "position": "6055"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "G2019S"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005225"
  },
  "Experiment Method": [
    {
      "Assay Method": "GST pull-down",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293T",
        "Description": "The experiment was conducted using HEK293T cells expressing LRRK2 variants."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_004494.4:c.5095T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "loss-of-function",
          "Result Description": "Reduced binding to Rab10 in GST pull-down assays for Y1699C."
        },
        {
          "Variant": "NM_004494.4:c.6055G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased binding to Rab10 in GST pull-down assays for G2019S."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Student's t-test was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Binding activity > 50% compared to wild-type.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Binding activity < 30% or > 150% compared to wild-type.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Co-immunoprecipitation",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293T",
        "Description": "Co-immunoprecipitation was performed in HEK293T cells expressing LRRK2 variants."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_004494.4:c.5095T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "loss-of-function",
          "Result Description": "Reduced co-immunoprecipitation of Rab10 with Y1699C LRRK2."
        },
        {
          "Variant": "NM_004494.4:c.6055G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Enhanced co-immunoprecipitation of Rab10 with G2019S LRRK2."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in duplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Co-immunoprecipitation signal > 40% compared to wild-type.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Co-immunoprecipitation signal < 20% or > 120% compared to wild-type.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Western blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "Western blot was performed in HEK293 cells expressing LRRK2 variants."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_004494.4:c.5095T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "loss-of-function",
          "Result Description": "Reduced LRRK2 phosphorylation at S935 in Western blot for Y1699C."
        },
        {
          "Variant": "NM_004494.4:c.6055G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased LRRK2 phosphorylation at S935 in Western blot for G2019S."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Student's t-test was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Phosphorylation level > 60% compared to wild-type.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Phosphorylation level < 40% or > 130% compared to wild-type.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Quantitative GST pull-down",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "Quantitative GST pull-down was performed in HEK293 cells expressing LRRK2 variants."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_004494.4:c.5095T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "loss-of-function",
          "Result Description": "Reduced binding to Rab10 in quantitative GST pull-down for Y1699C."
        },
        {
          "Variant": "NM_004494.4:c.6055G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased binding to Rab10 in quantitative GST pull-down for G2019S."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Binding activity > 55% compared to wild-type.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Binding activity < 35% or > 140% compared to wild-type.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}